WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
Year-over-year operating income growth rate
Latest
0.93%
↓ 99% vs avg
Percentile
P49
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
95.25%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.93% |
| Q3 2025 | -64.69% |
| Q2 2025 | 113.94% |
| Q1 2025 | -51.99% |
| Q4 2024 | -15.95% |
| Q3 2024 | 31.95% |
| Q2 2024 | 227.67% |
| Q1 2024 | -67.13% |
| Q4 2023 | -17.67% |
| Q3 2023 | 44.23% |
| Q2 2023 | 42.49% |
| Q1 2023 | -22.76% |
| Q4 2022 | -13.70% |
| Q3 2022 | 44.08% |
| Q2 2022 | 70.46% |
| Q1 2022 | -68.11% |
| Q4 2021 | -19.56% |
| Q3 2021 | 12.29% |
| Q2 2021 | 3508.62% |
| Q1 2021 | -95.82% |
| Q4 2020 | -8.25% |
| Q3 2020 | 60.36% |
| Q2 2020 | 354.27% |
| Q1 2020 | -120.63% |
| Q4 2019 | 30.24% |
| Q3 2019 | -3.68% |
| Q2 2019 | 780.26% |
| Q1 2019 | -112.14% |
| Q4 2018 | -14.23% |
| Q3 2018 | 9.02% |
| Q2 2018 | 189.86% |
| Q1 2018 | -64.56% |
| Q4 2017 | 19.16% |
| Q3 2017 | 33.91% |
| Q2 2017 | 284.01% |
| Q1 2017 | -355.33% |
| Q4 2016 | -132.16% |
| Q3 2016 | 27.20% |
| Q2 2016 | 114.42% |
| Q1 2016 | -940.89% |